Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2015 | 07-2015 | 04-2015 | 01-2015 | 10-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,008 | 6,792 | 9,151 | 2,723 | 4,814 |
| Receivables | 278 | 491 | 266 | 271 | 328 |
| TOTAL | $5,371 | $7,467 | $9,642 | $3,175 | $5,174 |
| Non-Current Assets | |||||
| PPE Net | 321 | 329 | 355 | 386 | 419 |
| TOTAL | $321 | $329 | $355 | $386 | $419 |
| Total Assets | $5,692 | $7,796 | $9,997 | $3,561 | $5,593 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 770 | 262 | 502 | 514 | 248 |
| Accrued Expenses | 598 | 707 | 623 | 660 | 555 |
| TOTAL | $1,368 | $969 | $1,125 | $1,174 | $803 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,368 | $969 | $1,125 | $1,174 | $803 |
| Shareholders' Equity | |||||
| Common Shares | 112,307 | 112,288 | 112,288 | 107,186 | 107,079 |
| Retained earnings | -138,248 | -135,656 | -133,537 | -131,716 | -129,051 |
| Other shareholders' equity | 11,314 | 11,740 | 11,666 | 10,843 | 12,188 |
| TOTAL | $4,324 | $6,827 | $8,872 | $2,387 | $4,790 |
| Total Liabilities And Equity | $5,692 | $7,796 | $9,997 | $3,561 | $5,593 |